BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15908978)

  • 1. Chagas disease in bone marrow transplantation: an approach to preemptive therapy.
    Altclas J; Sinagra A; Dictar M; Luna C; Verón MT; De Rissio AM; García MM; Salgueira C; Riarte A
    Bone Marrow Transplant; 2005 Jul; 36(2):123-9. PubMed ID: 15908978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recipients and donors of bone marrow transplants suffering from Chagas' disease: management and preemptive therapy of parasitemia.
    Dictar M; Sinagra A; Verón MT; Luna C; Dengra C; De Rissio A; Bayo R; Ceraso D; Segura E; Koziner B; Riarte A
    Bone Marrow Transplant; 1998 Feb; 21(4):391-3. PubMed ID: 9509974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benznidazole alters the pattern of Cyclophosphamide-induced reactivation in experimental Trypanosoma cruzi-dependent lineage infection.
    Santos DM; Martins TA; Caldas IS; Diniz LF; Machado-Coelho GL; Carneiro CM; Oliveira Rde P; Talvani A; Lana M; Bahia MT
    Acta Trop; 2010 Feb; 113(2):134-8. PubMed ID: 19854145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivation of Chagas' disease: cutaneous manifestations in two immunosuppressed patients.
    Riganti J; Maqueda MG; Piñero MC; Volonteri VI; Galimberti RL
    Int J Dermatol; 2012 Jul; 51(7):829-34. PubMed ID: 22715827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term evaluation of etiological treatment of chagas disease with benznidazole.
    Cancado JR
    Rev Inst Med Trop Sao Paulo; 2002; 44(1):29-37. PubMed ID: 11896410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chagas disease and liver transplantation: Experience in Argentina using real-time quantitative PCR for early detection and treatment.
    Balderramo D; Bonisconti F; Alcaraz A; Giordano E; Sánchez A; Barrabino M; Caeiro JP; Alvarellos T; Maraschio M
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28941300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmission of T. cruzi infection via liver transplantation to a nonreactive recipient for Chagas' disease.
    Barcán L; Luna C; Clara L; Sinagra A; Valledor A; De Rissio AM; Gadano A; García MM; de Santibañes E; Riarte A
    Liver Transpl; 2005 Sep; 11(9):1112-6. PubMed ID: 16123968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chagas' disease after bone marrow transplantation.
    Altclas J; Jaimovich G; Milovic V; Klein F; Feldman L
    Bone Marrow Transplant; 1996 Aug; 18(2):447-8. PubMed ID: 8864461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seronegative conversion after incomplete benznidazole treatment in chronic Chagas disease.
    Alvarez MG; Vigliano C; Lococo B; Petti M; Bertocchi G; Viotti R
    Trans R Soc Trop Med Hyg; 2012 Oct; 106(10):636-8. PubMed ID: 22898619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung function, pulmonary complications, and mortality after allogeneic blood and marrow transplantation in children.
    Kaya Z; Weiner DJ; Yilmaz D; Rowan J; Goyal RK
    Biol Blood Marrow Transplant; 2009 Jul; 15(7):817-26. PubMed ID: 19539213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using polymerase chain reaction in early diagnosis of re-activated Trypanosoma cruzi infection after heart transplantation.
    Maldonado C; Albano S; Vettorazzi L; Salomone O; Zlocowski JC; Abiega C; Amuchastegui M; Córdoba R; Alvarellos T
    J Heart Lung Transplant; 2004 Dec; 23(12):1345-8. PubMed ID: 15607662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
    Broers AE; van der Holt B; Haze S; Braakman E; Gratama JW; Löwenberg B; Cornelissen JJ
    Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chagas' disease reactivation with skin symptoms in a patient with kidney transplant.
    Gallerano V; Consigli J; Pereyra S; Gómez Zanni S; Danielo C; Gallerano RH; Guidi A
    Int J Dermatol; 2007 Jun; 46(6):607-10. PubMed ID: 17550560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivation of chronic Chagas' disease following allogeneic bone marrow transplantation and successful pre-emptive therapy with benznidazole.
    Altclas J; Sinagra A; Jaimovich G; Salgueira C; Luna C; Requejo A; Milovic V; De Rissio A; Feldman L; Riarte A
    Transpl Infect Dis; 1999 Jun; 1(2):135-7. PubMed ID: 11428981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and monitoring of human cytomegalovirus infection in bone marrow transplant recipients by quantitative competitive PCR.
    Ziyaeyan M; Sabahi F; Alborzi A; Mahboudi F; Kazemnejad A; Ramzi M; Moravej A; Jaberi MM
    Exp Clin Transplant; 2006 Jun; 4(1):470-4. PubMed ID: 16827646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma.
    Aksentijevich I; Jones RJ; Ambinder RF; Garrett-Mayer E; Flinn IW
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):965-72. PubMed ID: 16920563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Trypanosoma cruzi high parasitemia in patient with systemic lupus erythematosus].
    dos Santos-Neto LL; Polcheira MF; Castro C; Lima RA; Simaan CK; Corrêa-Lima FA
    Rev Soc Bras Med Trop; 2003; 36(5):613-5. PubMed ID: 14576877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute chagasic myocardiopathy after orthotopic liver transplantation with donor and recipient serologically negative for Trypanosoma cruzi: a case report.
    Souza FF; Castro-E-Silva O; Marin Neto JA; Sankarankutty AK; Teixeira AC; Martinelli AL; Gaspar GG; Melo L; Figueiredo JF; Romano MM; Maciel BC; Passos AD; Rossi MA
    Transplant Proc; 2008 Apr; 40(3):875-8. PubMed ID: 18455041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941.
    Gaynon PS; Harris RE; Altman AJ; Bostrom BC; Breneman JC; Hawks R; Steele D; Zipf T; Stram DO; Villaluna D; Trigg ME
    J Clin Oncol; 2006 Jul; 24(19):3150-6. PubMed ID: 16717292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events after the use of benznidazole in infants and children with Chagas disease.
    Altcheh J; Moscatelli G; Moroni S; Garcia-Bournissen F; Freilij H
    Pediatrics; 2011 Jan; 127(1):e212-8. PubMed ID: 21173000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.